Content
All Posts > Content under Healthcare
Gilead Misses Q1 Earnings And Revenue Estimates, Stock Drops
Article By:
Zacks Investment Research
Read
Tuesday, May 2, 2017 8:50 PM EDT
Gilead Sciences released its first quarter fiscal 2017 financial results, posting earnings of $2.23 per share and revenues of $6.5 billion.
In this article: GILD
Gilead Sciences Reports Worse-Than-Expected Q1 Earnings; Revenues Plunge 16.5% Y-O-Y
Article By:
Lorimer Wilson
Read
Tuesday, May 2, 2017 5:25 PM EDT
Gilead Sciences, Inc. posted worse than expected first quarter earnings and revenue results, as sales of its HCV focused drugs plummeted 40% from last year.
In this article: GILD
Novartis Grabs Licenses On New Tech For Next-Gen Therapies For CAR-T
Article By:
Lorimer Wilson
Read
Tuesday, May 2, 2017 3:30 PM EDT
The Belgian biotech Celyad announced that Novartis had gained non-exclusive rights to IP it has on allogeneic CAR-Ts, off-the-shelf cell therapies for cancer that could eventually prove superior to the autologous programs now lining up for approval.
Pfizer And Apple In Focus
Article By:
Zacks Investment Research
Read
Tuesday, May 2, 2017 2:07 PM EDT
Apple, Inc., not only the biggest tech firm but the world’s largest company by market cap, is expected to bring in $2.02 per share on $52.61 billion in quarterly sales after today’s closing bell.
Aetna Inc. Boosts EPS Outlook Despite Negative Q1 Revenue Growth
Article By:
Lorimer Wilson
Read
Tuesday, May 2, 2017 11:36 AM EDT
Aetna Inc. posted mixed first quarter earnings results and lifted its full-year forecast, despite a downturn in revenue that missed expectations.
In this article: AET
CVS Health Corp. Reaffirms Outlook As Q1 Earnings Top Expectations
Article By:
Lorimer Wilson
Read
Tuesday, May 2, 2017 9:02 AM EDT
CVS Health Corp. early Tuesday posted better than expected first-quarter earnings, offered an in-line outlook for Q2, and reiterated its full-year forecast.
In this article: CVS
Pfizer Inc. Shares Rise After Earnings, Merck & Co., Inc. Shares Decline
Article By:
ValueWalk
Read
Tuesday, May 2, 2017 8:09 AM EDT
Pfizer and Merck released their latest earnings reports before opening bell this morning. Pfizer reported adjusted earnings of 69 cents per share on $12.8 billion in revenue, compared to the analyst estimates of 67 cents per share and $13.1 billion.
Prem Watsa’s Dividend Stock Portfolio: Every Holding Analyzed
Article By:
SureDividend
Read
Tuesday, May 2, 2017 2:56 AM EDT
As the Chief Executive Officer of Fairfax Financial Holdings Ltd., Watsa is the portfolio manager for an impressive sum of insurance float. Let's analyze Prem Watsa’s dividend stock investment portfolio in detail.
In this article: GD, HP, IBM, JNJ, KW, LUK, MON, NOV, PFE, PKX, USB, VAL, WFC, BWINB, NTES, RYAM Also: BRK-A, BRK-B, FRFHF
Bio-Rad Laboratories - Chart Of The Day
Article By:
Jim Van Meerten
Read
Monday, May 1, 2017 11:50 PM EDT
Since the Trend Spotter signaled a buy on 4/4 the stock jumped 8.99%.
In this article: BIO
Sector Strength - Monday, May 1
Article By:
Douglas Gammons
Read
Monday, May 1, 2017 10:56 PM EDT
A new short-term up-trend started on April-20, but this up-trend might already be starting to falter.
In this article: XBI, SPX, SPXEW Also: XIV(RETIRED), INDY, QQQ, SOXX, EEM, EFA, EWJ, EWW, ITB, RSX, RTH, SPY, VGK, XLB, XLK, XLU, XLV, XLY, XLRE
2017 Biotech Breakout Coming
Article By:
Rod Raynovich
Read
Monday, May 1, 2017 8:56 PM EDT
We expect a biotech breakout to 52 week highs in the coming months because of new products, good clinical news and M&A. Biotech has survived several tweet storms from Trump and many negative articles on drug pricing.
Cardinal Health (CAH) Q3 Earnings Beat Estimates, Rise Y/Y
Article By:
Zacks Investment Research
Read
Monday, May 1, 2017 2:32 PM EDT
Cardinal Health Inc (CAH- Free Report) reported third-quarter fiscal 2017 adjusted earnings of $1.53 per share, which beat the Zacks Consensus Estimate of $1.46 and increased 7% on a year-over-year basis.
Cardinal Health (CAH) Tops Q3 Earnings, Miss On Revenues
Article By:
Zacks Investment Research
Read
Monday, May 1, 2017 9:50 AM EDT
Cardinal Health’s adjusted earnings rose 7% on a year-over-year basis to $1.53 per share. Revenues increased 4% on a year-over-year basis to $31.8 billion.
In this article: CAH
Key Events In The Coming Busy Week: FOMC, Payrolls, 131 S&P Companies Report
Article By:
Tyler Durden
Read
Monday, May 1, 2017 8:46 AM EDT
Besides the upcoming FOMC meeting on May 2-3, and French & Italian politics - the decisive runoff round of the French election takes place this Sunday - this week's releases are dominated by US payrolls expected to come around 170k.